283 related articles for article (PubMed ID: 29156849)
1. Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update.
Malric L; Monferran S; Gilhodes J; Boyrie S; Dahan P; Skuli N; Sesen J; Filleron T; Kowalski-Chauvel A; Cohen-Jonathan Moyal E; Toulas C; Lemarié A
Oncotarget; 2017 Oct; 8(49):86947-86968. PubMed ID: 29156849
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy to checkmate Glioblastoma: clinical challenges and advances.
Ghosh D; Nandi S; Bhattacharjee S
Clin Transl Med; 2018 Oct; 7(1):33. PubMed ID: 30327965
[TBL] [Abstract][Full Text] [Related]
3. The Glioblastoma Landscape: Hallmarks of Disease, Therapeutic Resistance, and Treatment Opportunities.
Boylan J; Byers E; Kelly DF
Med Res Arch; 2023 Jun; 11(6):. PubMed ID: 38107346
[TBL] [Abstract][Full Text] [Related]
4. Cancer Stem Cells and Glioblastoma: Time for Innovative Biomarkers of Radio-Resistance?
Pasqualetti F; Miniati M; Gonnelli A; Gadducci G; Giannini N; Palagini L; Mancino M; Fuentes T; Paiar F
Biology (Basel); 2023 Sep; 12(10):. PubMed ID: 37887005
[TBL] [Abstract][Full Text] [Related]
5. Biomimetic Approach of Brain Vasculature Rapidly Characterizes Inter- and Intra-Patient Migratory Diversity of Glioblastoma.
Crestani M; Kakogiannos N; Iori S; Iannelli F; Dini T; Maderna C; Giannotta M; Pelicci G; Maiuri P; Monzo P; Gauthier NC
Small Methods; 2024 May; ():e2400210. PubMed ID: 38747088
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma Stem Cells: A Neuropathologist's View.
McLendon RE; Rich JN
J Oncol; 2011; 2011():397195. PubMed ID: 21052560
[TBL] [Abstract][Full Text] [Related]
7. Comment on Mahajan, S.; Schmidt, M.H.H. Distinct Lineage of Slow-Cycling Cells Amidst the Prevailing Heterogeneity in Glioblastoma.
Yang C; Mitchell DA; Deleyrolle LP
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254768
[TBL] [Abstract][Full Text] [Related]
8. Targeting cancer cell metabolism in glioblastoma.
Crunkhorn S
Nat Rev Drug Discov; 2019 Mar; ():. PubMed ID: 31048798
[No Abstract] [Full Text] [Related]
9. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
[TBL] [Abstract][Full Text] [Related]
10. Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible?
Santamaria S; Delgado M; Kremer L; Garcia-Sanz JA
Front Immunol; 2017; 8():1509. PubMed ID: 29170667
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting Integrin β8 to Differentiate and Radiosensitize Glioblastoma-Initiating Cells.
Malric L; Monferran S; Delmas C; Arnauduc F; Dahan P; Boyrie S; Deshors P; Lubrano V; Da Mota DF; Gilhodes J; Filleron T; Siegfried A; Evrard S; Kowalski-Chauvel A; Moyal EC; Toulas C; Lemarié A
Mol Cancer Res; 2019 Feb; 17(2):384-397. PubMed ID: 30266751
[TBL] [Abstract][Full Text] [Related]
12. The Potential Role of the Extracellular Matrix Glycoprotein Reelin in Glioblastoma Biology.
Ongemach E; Zerrinius D; Heimann P; Wirtz CR; Debatin KM; Westhoff MA; Peraud A
Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543187
[TBL] [Abstract][Full Text] [Related]
13. Glioma Cells Secrete Collagen VI to Facilitate Invasion.
Cha J; Ding EA; Carvalho EM; Fowler A; Aghi MK; Kumar S
bioRxiv; 2023 Dec; ():. PubMed ID: 38168332
[TBL] [Abstract][Full Text] [Related]
14. GPR56 signaling pathway network and its dynamics in the mesenchymal transition of glioblastoma.
Ganesh RA; Venkataraman K; Sirdeshmukh R
J Cell Commun Signal; 2023 Dec; 17(4):1527-1535. PubMed ID: 37980704
[TBL] [Abstract][Full Text] [Related]
15. Effect of Dimeric Disintegrins Isolated from
Galicka A; Szoka Ł; Radziejewska I; Marcinkiewicz C
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835499
[TBL] [Abstract][Full Text] [Related]
16. Cdk4 Regulates Glioblastoma Cell Invasion and Stemness and Is Target of a Notch Inhibitor Plus Resveratrol Combined Treatment.
Giordano F; D'Amico M; Montalto FI; Malivindi R; Chimento A; Conforti FL; Pezzi V; Panno ML; Andò S; De Amicis F
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373242
[TBL] [Abstract][Full Text] [Related]
17. A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas.
Di Filippo LD; de Carvalho SG; Duarte JL; Luiz MT; Paes Dutra JA; de Paula GA; Chorilli M; Conde J
Mater Today Bio; 2023 Jun; 20():100671. PubMed ID: 37273792
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors.
Biswas A; Salvucci M; Connor K; Düssmann H; Carberry S; Fichtner M; King E; Murphy B; O'Farrell AC; Cryan J; Beausang A; Heffernan J; Cremona M; Hennessy BT; Clerkin J; Sweeney KJ; MacNally S; Brett F; O'Halloran P; Bacon O; Furney S; Verreault M; Quissac E; Bielle F; Ahmed MH; Idbaih A; Leenstra S; Ntafoulis I; Fabro F; Lamfers M; Golebiewska A; Hertel F; Niclou SP; Yen RTC; Kremer A; Dilcan G; Lodi F; Arijs I; Lambrechts D; Purushothama MK; Kel A; Byrne AT; Prehn JHM
J Neurooncol; 2023 Jun; 163(2):327-338. PubMed ID: 37237151
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
